Virtual clinical trials now being used to fast-track drug development during coronavirus crisis

Other prominent start-ups in the space include Science 37, a full-service virtual trial platform, and Unlearn.AI, a service that creates digital twins of patients to expand data sets. In April, Unlearn.A1 received $12 million in Series A financing led by 8VC.

The U.S. Food and Drug Administration also helped clear the path to virtual trials in March by issuing guidelines for clinical studies during the pandemic that included “evaluating alternative methods for assessments, like phone contacts or virtual visits, and offering additional safety monitoring for those trial participants who may no longer have access to investigational product or the investigational site.”

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Blog

Announcing The Unlearn Opportunities Internship Program

Podcasts

UCSF Rosenman Institute - The Health Technology Podcast #59: Digital Twins for Clinical Trials

Podcasts

The Health-Tech Podcast #111: The Story of Unlearn.ai with Charles Fisher

The Health-Tech Podcast covers the latest in health and technology through interviews with disruptive health-tech startups and leaders.
Charles Fisher: Digital Twins for Clinical Trials
Creating Opportunities for Students of Data Science and Business from Underrepresented Groups in STEM